Analysis of humoral immune response in experimental autoimmune pancreatitis in mice

Pancreas

Volumn 39, Issue 2, 2010, Pages 224-231

  Asada, Masanori ^a   Nishio, Akiyoshi ^b   Akamatsu, Takuji ^c   Tanaka, Junya ^c   Saga, Kazuyuki ^c   Kido, Masahiro ^c   Watanabe, Norihiko ^c   Uchida, Kazushige ^b   Fukui, Toshiro ^b   Okazaki, Kazuichi ^b   Chiba, Tsutomu ^c  

^a Kitano Hospital   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Autoantibody; Autoimmune pancreatitis; Pancreatic secretory trypsin inhibitor

Indexed keywords

APROTININ; AUTOANTIBODY; CARBONATE DEHYDRATASE II; IMMUNOGLOBULIN G; LACTOFERRIN; POLYINOSINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE PANCREATITIS; BLOOD CHEMISTRY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FEMALE; HUMORAL IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD45; AUTOANTIBODIES; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CARBONIC ANHYDRASE II; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FEMALE; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; LACTOFERRIN; MICE; MICE, INBRED C57BL; PANCREAS; PANCREATITIS; PLASMA CELLS; POLY I-C; SYNDECAN-1; TRYPSIN INHIBITOR, KAZAL PANCREATIC;

EID: 77649256624     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181bab5e2     Document Type: Article

References (36)

1. Steer ML, Waxman I, Freedman S. Chronic pancreatitis. N Eng J Med. 1995;332:1482-1490.
2. Sarles H, Sarles JC, Muratore R, et al. Chronic inflammatory sclerosis of the pancreasVan autonomous pancreatic disease? Am J Dig Dis. 1961;6:688-698.
3. Okazaki K, Uchida K, Matsushita M, et al. Autoimmune pancreatitis. Intern Med. 2005;44:1215-1223.
4. Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40:1561-1568.
5. Okazaki K, Chiba T. Autoimmune related pancreatitis. Gut. 2005;40:1-4.
6. Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol. 2006;4:1010-1016.
7. Okazaki K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol. 2006; 41:626-631.
8. Kim MH, Kwon S. Diagnostic criteria for autoimmune chronic pancreatitis. J Gastroenterol. 2007;42(suppl 18):42-49.
9. Klöppel G, Sipos B, Zamboni G, et al. Autoimmune pancreatitis: histo- and immunopathological features. J Gastroenterol. 2007;42 (suppl 18):28-31.
10. Uchida K, Okazaki K, Konishi Y, et al. Clinical analysis of autoimmune-related pancreatitis. Am J Gastroenterol. 2000;95: 2788-2794.
11. Okazaki K, Uchida K, Chiba T. Recent concept of autoimmune-related pancreatitis. J Gastroenterol. 2001;36:293-302.
12. Uchida K, Okazaki K, Nishi T, et al. Experimental immune-mediated pancreatitis in neonatally thymectomized mice immunized with carbonic anhydralse II and lactoferrin. Lab Invest. 2002;82:411-424.
13. Nishimori I, Miyaji E, Morimoto K, et al. Serum antibodies to carbonic anhydrase IV in patients with autoimmune pancreatitis. Gut. 2005; 54:274-281.
14. Asada M, Nishio A, Uchida K, et al. Identification of a novel autoantibody against pancreatic secretory trypsin inhibitor in patients with autoimmune pancreatitis. Pancreas. 2006;33:20-26.
15. Kanno H, Nose M, Itoh J, et al. Spontaneous development of pancreatitis in the MRL/Mp strain of mice in autoimmune mechanism. Clin Exp Immunol. 1992;89:68-73.
16. Hosaka N, Nose M, Kyogoku M, et al. Thymus transplantation, a critical factor for correction of autoimmune disease in aging MRL/+ mice. Proc Natl Acad Sci U S A. 1996;93:8558-8562.
17. Tsubata R, Tsubata T, Hiai H, et al. Autoimmune disease of exocrine organs in immunodeficient alymphoplasia mice: a spontaneous model of Sjögren's syndrome. Eur J Immunol. 1996;26:2742-2748.
18. Valance BA, Hewlett BR, Snider DP, et al. T cell-mediated exocrine pancreatic damage in major histocompatibility complex class II-deficient mice. Gastroenterology. 1998;115:978-987.
19. Qu WM, Miyazaki T, Terada M, et al. A novel autoimmune pancreatitis model in MRL mice treated with polyinosinic: polycytidylic acid. Clin Exp Immunol. 2002;129:26-34.
20. Davidson TS, Longnecker DS, Hickey WF. An experimental model of autoimmune pancreatitis in the rat. Am J Pathol. 2005;166:729-736.
21. Meagher C, Tang Q, Fife BT, et al. Spontaneous development of a pancreatic exocrine disease in CD28-deficient NOD mice. J Immunol. 2008;180:7793-7803.
22. Nahon UK, Levy P, O'Toole D, et al. Is idiopathic chronic pancreatitis an autoimmune disease? Clin Gastroenterol Hepatol. 2005;3:903-909.
23. Steinberg AD, Baron S, Talal N. The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid. Proc Natl Acad Sci U S A. 1969;63: 1102-1107.
24. Kobayashi Y, Murakami H, Akbar SMF, et al. A novel and effective approach of developing aggressive experimental autoimmune gastritis in neonatal thymectomized BALB/c mouse by polyinosinic: polycytidylic acid. Clin Exp Immunol. 2004;136:423-431.
25. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Eng J Med. 2001;344: 732-738.
26. Aparisi L, Farre A, Gomez-Cambronero L, et al. Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis. Gut. 2005;54: 703-709.
27. Yamamoto T, Nakamura Y, Nishide J, et al. Molecular cloning and nucleotide sequence of human pancreatic trypsin inhibitor (PSTI) cDNA. Biochem Biophys Res Commun. 1985;132:605-612.
28. Bartelt DC, Shapanka R, Greene LJ. The primary structure of the human pancreatic secretory trypsin inhibitor. Amino acid sequence of the reduced S-aminoethylated protein. Arch Biochem Biophys. 1977; 179:189-199.
29. Ohlsson K, Olsson R, Björk P, et al. Local administration of human pancreatic secretory inhibitor prevents the development of experimental acute pancreatitis in rats and dogs. Scand J Gastroenterol. 1989;24: 693-704.
30. Funakoshi A, Miyasaka K, Jimi A, et al. Protective effect of human pancreatic secretory trypsin inhibitor on cerulein-induced acute pancreatitis in rats. Digestion. 1992;52:145-151.
31. Chen YZ, Ikei S, Yamaguchi Y, et al. The protective effects of long-acting recombinant human trypsin inhibitor on cerulein-induced pancreatitis. J Int Med Res. 1996;24:59-68.
32. Nathan JD, Romac J, Peng RY, et al. Transgenic expression of pancreatic secretory trypsin inhibitor-I ameliorates secretagogue-induced acute pancreatitis in mice. Gastroenterology. 2005;128:716-727.
33. Böldicke T, Kindt S, Maywald F, et al. Production of specific monoclonal antibodies against the active sites of human pancreatic secretory trypsin inhibitor variants by in vitro immunization with synthetic peptides. Eur J Biochem. 1988;175:259-264.
34. Witt H, Luck W, Hennies HC, et al. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet. 2000;25:213-216.
35. Pfutzer RH, Barmada MM, Brunskill AP, et al. SPINK/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology. 2000;119:615-623.
36. Okazaki K, Uchida K, Ohana M, et al. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology. 2000;118:573-581.